Clinical Trials Browser

NETWORK × Prostatic Neoplasms × Radiotherapy × Clear all

NCT02799706 2026-05-22

PEGASUS

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT01546987 2026-03-06

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Phase 3 Completed

239 enrolled 38 charts

Prostatic Neoplasms

NCT03678025 2025-09-11

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Phase 3 Recruiting

Prostatic Neoplasms

NCT00651326 2023-08-04

DART

Phase 3 Terminated

Prostatic Neoplasms

NCT00288080 2022-06-21

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3 Completed

612 enrolled 11 charts

Prostatic Neoplasms

NCT00002874 2022-06-15

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Phase 3 Completed

840 enrolled 17 charts

Prostatic Neoplasms

NCT00005044 2022-06-15

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

1,579 enrolled 13 charts

Prostatic Neoplasms

NCT00004054 2020-10-22

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

397 enrolled 11 charts

Prostatic Neoplasms

NCT00006365 2020-10-22

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00023829 2020-10-22

Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT03488810 2020-08-17

ARN-509

Phase 3 Withdrawn

Prostatic Neoplasms

NCT00002633 2020-04-03

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00528866 2019-04-24

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Phase 2 Completed

80 enrolled 11 charts

Prostatic Neoplasms

NCT00002597 2018-06-14

Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 3 Completed

2,028 enrolled 15 charts

Prostatic Neoplasms

NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Phase 3 Completed

109 enrolled 8 charts

Osteoporosis, Prostatic Neoplasms

NCT00551525 2017-07-25

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Phase 2 Completed

67 enrolled 10 charts

Prostatic Neoplasms

NCT00769548 2017-01-04

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00021450 2016-09-02

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00003162 2015-11-17

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Phase 3 Completed

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT00849082 2012-07-11

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00003026 2012-07-02

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms